Figure 5.
Cut-off selection of serum Hsp90-beta by ROC curve analysis. A. Data distribution of serum value of Hsp90-beta in distinguishing lung cancer patients from benign group; B. Selection of cut-off for serum value of Hsp90-beta in distinguishing lung cancer patients from benign group; C. Receiver operating characteristic curves for serum [area under the curve (AUC): 0.915]; ROC, receiver operating characteristic curve.